There are 749 resources available
Invited Discussant 224O, 225O and LBA10
Presenter: Cristiana Sessa
Session: Proffered paper session - Gynaecological cancers
Resources:
Slides
Invited Discussant One LBA11 and 226O
Presenter: Mansoor Raza Mirza
Session: Proffered paper session - Gynaecological cancers
Resources:
Slides
Liquid biomarkers for NSCLC
Presenter: Yasushi Goto
Session: Perspective of liquid biomarkers for cancer care
Resources:
Slides
Webcast
Optimal first-line treatment in mCRPC after either chemo or ARI in mHSPC
Presenter: Cora Sternberg
Session: ESMO Colloquium supported by Astellas - State of the art management of mCPRC
Resources:
Slides
Adopting new paradigm of treatment strategy into clinical practice: Multidisciplinary approach (from medical oncologist perspective)
Presenter: Su Pin Choo
Session: Eisai Co., Ltd. - New paradigm of treatment strategy for intermediate and advanced HCC
Resources:
Slides
Is there an optimal sequencing strategy in mCRPC?
Presenter: Ben Tran
Session: ESMO Colloquium supported by Astellas - State of the art management of mCPRC
Resources:
Slides
What does liquid biopsy mean?
Presenter: François Clément Bidard
Session: ESMO Colloquium supported by Guardant Health: Liquid biopsy in the management of solid tumours
Resources:
Slides
Use of liquid biopsies in colorectal cancers
Presenter: Takayuki Yoshino
Session: ESMO Colloquium supported by Guardant Health: Liquid biopsy in the management of solid tumours
Resources:
Slides
Changing paradigm of treatment strategy for intermediate and advanced HCC
Presenter: Masafumi Ikeda
Session: Eisai Co., Ltd. - New paradigm of treatment strategy for intermediate and advanced HCC
Resources:
Slides
Webcast
Adopting new paradigm of treatment strategy into clinical practice: Multidisciplinary approach (from loco-regional interventionist perspective)
Presenter: Shi-Ming Lin
Session: Eisai Co., Ltd. - New paradigm of treatment strategy for intermediate and advanced HCC
Resources:
Slides
Webcast